-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Linzagolix Choline in Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Linzagolix Choline in Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Linzagolix Choline in Pain Drug Details: Linzagolix (Yselty) is a small-molecule, non-peptide,...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Linzagolix Choline in Endometriosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Linzagolix Choline in Endometriosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Linzagolix Choline in Endometriosis Drug Details: Linzagolix (Yselty) is a small-molecule, non-peptide,...
-
Product Insights
Florida Univ – UF Data Science and Information Technology Center – Florida
Equip yourself with the essential tools needed to make informed and profitable decisions with our Florida Univ - UF Data Science and Information Technology Center - Florida report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
Florida Univ – UF Norman Hall Rehabilitation and College of Education Center – Florida
Equip yourself with the essential tools needed to make informed and profitable decisions with our Florida Univ - UF Norman Hall Rehabilitation and College of Education Center - Florida report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the...
-
Product Insights
Renal Dialysis Equipment Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Renal Dialysis Equipment Pipeline Market Report Overview Renal dialysis equipment is intended to provide an artificial replacement for lost kidney function due to renal failure. Dialysis machines, dialysis accessories, vascular access devices for hemodialysis, and stone management disposables are covered in this category. The renal dialysis equipment pipeline market research report provides comprehensive information about the renal dialysis equipment pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which...
-
Company Profile
Encore Wire Corp – Company Profile
Encore Wire Corp (Encore) is a manufacturer of electrical building wire and cable for interior electrical wiring in residential, commercial and industrial buildings. Its major products include UF-B cable, NM-B cable, THHN/THWN-2, SE style cable (style U and style R), XHHW-2, USE-2 or RHH or RHW-2, tray cable, metal-clad cable, armored cable, photovoltaic single-conductor cable, and mobile home feeder cable. The company manufactures its products using copper cathode, copper scrap, PVC thermoplastic compounds, XLPE compounds, aluminum, steel, paper and nylon....
Add to Basket -
Product Insights
Net Present Value Model: Yselty
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Yselty Drug Details Linzagolix (Yselty) is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – linzagolix choline
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry linzagolix choline Drug Details Linzagolix (Yselty) is a small-molecule, non-peptide, orally active gonadotropin-releasing hormone...
-
Product Insights
Peritoneal Dialysis Equipment Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021
Peritoneal dialysis equipment, also called cyclers, are used in continuous cycler-assisted peritoneal dialysis to fill and drain the abdomen, usually while a patient sleep. GlobalData's Medical Devices sector report, “Peritoneal Dialysis Equipment - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Peritoneal Dialysis Equipment pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Peritoneal Dialysis Equipment report provides key information and data...
-
Sector Analysis
Gene Therapy in CVMD
Gene therapies have been a point of discussion during the last several years as a potential curative option for a variety of disease indications. While mainly still in preclinical stages, gene therapy aims to treat or alleviate a disease by genetically modifying the cells of a patient. This report focuses on gene therapies in development across the 8MM for cardiovascular and metabolic disorders, including coronary artery disease, critical limb ischemia, diabetic foot ulcers, and Pompe Disease. In addition, this report...